nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ORM1—Vemurafenib—melanoma	0.15	0.33	CbGbCtD
Olanzapine—ALB—melanoma	0.131	0.512	CbGaD
Olanzapine—ABCB1—melanoma	0.125	0.488	CbGaD
Olanzapine—ALB—Vemurafenib—melanoma	0.063	0.139	CbGbCtD
Olanzapine—CYP1A2—Carmustine—melanoma	0.0477	0.105	CbGbCtD
Olanzapine—CYP1A2—Vemurafenib—melanoma	0.0377	0.083	CbGbCtD
Olanzapine—CYP3A4—Temozolomide—melanoma	0.036	0.0794	CbGbCtD
Olanzapine—CYP2D6—Vemurafenib—melanoma	0.0311	0.0684	CbGbCtD
Olanzapine—CYP1A2—Dacarbazine—melanoma	0.0289	0.0636	CbGbCtD
Olanzapine—ABCB1—Dactinomycin—melanoma	0.0219	0.0483	CbGbCtD
Olanzapine—CYP3A4—Vemurafenib—melanoma	0.0197	0.0435	CbGbCtD
Olanzapine—HTR1D—meninx—melanoma	0.0127	0.169	CbGeAlD
Olanzapine—DRD5—eyelid—melanoma	0.0115	0.153	CbGeAlD
Olanzapine—ABCB1—Docetaxel—melanoma	0.0113	0.0249	CbGbCtD
Olanzapine—CYP3A4—Docetaxel—melanoma	0.00678	0.0149	CbGbCtD
Olanzapine—CHRM5—skin epidermis—melanoma	0.00323	0.043	CbGeAlD
Olanzapine—HTR5A—head—melanoma	0.00223	0.0297	CbGeAlD
Olanzapine—H1F0—hair follicle—melanoma	0.00199	0.0264	CbGeAlD
Olanzapine—HTR2A—hindlimb—melanoma	0.0015	0.02	CbGeAlD
Olanzapine—HTR1B—blood vessel—melanoma	0.00149	0.0198	CbGeAlD
Olanzapine—HTR1D—blood vessel—melanoma	0.00144	0.0192	CbGeAlD
Olanzapine—FMO3—eye—melanoma	0.00135	0.018	CbGeAlD
Olanzapine—H1F0—neck—melanoma	0.00133	0.0177	CbGeAlD
Olanzapine—HTR2A—appendage—melanoma	0.00129	0.0171	CbGeAlD
Olanzapine—HTR7—endothelium—melanoma	0.00125	0.0166	CbGeAlD
Olanzapine—HTR7—blood vessel—melanoma	0.00115	0.0153	CbGeAlD
Olanzapine—CHRM5—eye—melanoma	0.00115	0.0153	CbGeAlD
Olanzapine—FMO3—mammalian vulva—melanoma	0.00107	0.0143	CbGeAlD
Olanzapine—HRH2—skin of body—melanoma	0.00105	0.0139	CbGeAlD
Olanzapine—CHRM5—skin of body—melanoma	0.001	0.0133	CbGeAlD
Olanzapine—H1F0—retina—melanoma	0.000983	0.0131	CbGeAlD
Olanzapine—HTR1E—head—melanoma	0.000952	0.0127	CbGeAlD
Olanzapine—H1F0—skin of body—melanoma	0.000863	0.0115	CbGeAlD
Olanzapine—CHRM4—head—melanoma	0.000835	0.0111	CbGeAlD
Olanzapine—HTR7—neck—melanoma	0.000823	0.0109	CbGeAlD
Olanzapine—H1F0—mammalian vulva—melanoma	0.000787	0.0105	CbGeAlD
Olanzapine—HTR2A—endothelium—melanoma	0.000777	0.0103	CbGeAlD
Olanzapine—DRD3—head—melanoma	0.000776	0.0103	CbGeAlD
Olanzapine—HTR1D—eye—melanoma	0.000768	0.0102	CbGeAlD
Olanzapine—FMO3—head—melanoma	0.000768	0.0102	CbGeAlD
Olanzapine—HTR6—head—melanoma	0.000747	0.00994	CbGeAlD
Olanzapine—DRD5—head—melanoma	0.000727	0.00968	CbGeAlD
Olanzapine—HTR2A—blood vessel—melanoma	0.000717	0.00954	CbGeAlD
Olanzapine—HRH2—head—melanoma	0.000683	0.00909	CbGeAlD
Olanzapine—CHRM5—head—melanoma	0.000653	0.00868	CbGeAlD
Olanzapine—HTR2B—skin of body—melanoma	0.000622	0.00827	CbGeAlD
Olanzapine—ADRA1B—head—melanoma	0.000596	0.00793	CbGeAlD
Olanzapine—DRD2—eye—melanoma	0.000578	0.0077	CbGeAlD
Olanzapine—DRD2—retina—melanoma	0.000573	0.00763	CbGeAlD
Olanzapine—H1F0—head—melanoma	0.000563	0.00749	CbGeAlD
Olanzapine—DRD1—head—melanoma	0.000556	0.0074	CbGeAlD
Olanzapine—FMO3—lymph node—melanoma	0.000537	0.00715	CbGeAlD
Olanzapine—HTR3A—head—melanoma	0.000537	0.00714	CbGeAlD
Olanzapine—HTR2A—neck—melanoma	0.000513	0.00682	CbGeAlD
Olanzapine—HRH2—lymph node—melanoma	0.000478	0.00637	CbGeAlD
Olanzapine—ABCB1—blood vessel—melanoma	0.00047	0.00625	CbGeAlD
Olanzapine—HRH1—eye—melanoma	0.000457	0.00608	CbGeAlD
Olanzapine—HTR1B—head—melanoma	0.00045	0.00599	CbGeAlD
Olanzapine—CHRM2—head—melanoma	0.000448	0.00596	CbGeAlD
Olanzapine—ADRA2C—mammalian vulva—melanoma	0.000446	0.00594	CbGeAlD
Olanzapine—HTR1D—head—melanoma	0.000436	0.0058	CbGeAlD
Olanzapine—HTR2C—head—melanoma	0.000432	0.00575	CbGeAlD
Olanzapine—CHRM1—head—melanoma	0.000408	0.00543	CbGeAlD
Olanzapine—HTR2B—head—melanoma	0.000406	0.0054	CbGeAlD
Olanzapine—H1F0—lymph node—melanoma	0.000394	0.00524	CbGeAlD
Olanzapine—HTR2A—eye—melanoma	0.000382	0.00508	CbGeAlD
Olanzapine—HTR2A—retina—melanoma	0.000378	0.00503	CbGeAlD
Olanzapine—CHRM3—head—melanoma	0.000365	0.00486	CbGeAlD
Olanzapine—HTR1A—head—melanoma	0.000363	0.00484	CbGeAlD
Olanzapine—HRH1—mammalian vulva—melanoma	0.000362	0.00482	CbGeAlD
Olanzapine—ADRA2A—mammalian vulva—melanoma	0.000356	0.00474	CbGeAlD
Olanzapine—HTR7—head—melanoma	0.000347	0.00462	CbGeAlD
Olanzapine—ORM1—lymph node—melanoma	0.000336	0.00448	CbGeAlD
Olanzapine—ADRA1A—head—melanoma	0.000335	0.00446	CbGeAlD
Olanzapine—DRD2—head—melanoma	0.000328	0.00437	CbGeAlD
Olanzapine—ADRA2C—head—melanoma	0.000319	0.00425	CbGeAlD
Olanzapine—ALB—lymph node—melanoma	0.000295	0.00392	CbGeAlD
Olanzapine—HTR2B—lymph node—melanoma	0.000284	0.00378	CbGeAlD
Olanzapine—HRH1—head—melanoma	0.000259	0.00345	CbGeAlD
Olanzapine—ADRA2A—head—melanoma	0.000255	0.00339	CbGeAlD
Olanzapine—ABCB1—retina—melanoma	0.000248	0.0033	CbGeAlD
Olanzapine—ADRA2C—lymph node—melanoma	0.000224	0.00297	CbGeAlD
Olanzapine—HTR2A—head—melanoma	0.000217	0.00288	CbGeAlD
Olanzapine—ABCB1—mammalian vulva—melanoma	0.000198	0.00264	CbGeAlD
Olanzapine—CYP2D6—head—melanoma	0.000197	0.00263	CbGeAlD
Olanzapine—HRH1—lymph node—melanoma	0.000182	0.00242	CbGeAlD
Olanzapine—ADRA2A—lymph node—melanoma	0.000178	0.00237	CbGeAlD
Olanzapine—ABCB1—head—melanoma	0.000142	0.00189	CbGeAlD
Olanzapine—ABCB1—lymph node—melanoma	9.94e-05	0.00132	CbGeAlD
Olanzapine—ADRA2B—Signaling Pathways—MAPK1—melanoma	2.19e-06	1.01e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—melanoma	2.18e-06	1.01e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NFKB1—melanoma	2.18e-06	1.01e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—melanoma	2.18e-06	1.01e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—melanoma	2.18e-06	1.01e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCB1—melanoma	2.18e-06	1.01e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—melanoma	2.18e-06	1.01e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—melanoma	2.17e-06	1.01e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—melanoma	2.17e-06	1.01e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—melanoma	2.17e-06	1.01e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—melanoma	2.17e-06	1.01e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—melanoma	2.16e-06	1e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—HRAS—melanoma	2.16e-06	1e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—melanoma	2.16e-06	1e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—melanoma	2.16e-06	1e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—melanoma	2.15e-06	9.97e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK3—melanoma	2.15e-06	9.96e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—melanoma	2.15e-06	9.96e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—melanoma	2.14e-06	9.94e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.13e-06	9.9e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—melanoma	2.13e-06	9.88e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—melanoma	2.13e-06	9.88e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—melanoma	2.12e-06	9.83e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—melanoma	2.11e-06	9.81e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK3—melanoma	2.11e-06	9.8e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CD—melanoma	2.11e-06	9.79e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK1—melanoma	2.11e-06	9.79e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—melanoma	2.11e-06	9.79e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—melanoma	2.1e-06	9.75e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK1—melanoma	2.1e-06	9.74e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—melanoma	2.1e-06	9.74e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—melanoma	2.09e-06	9.72e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	2.09e-06	9.71e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CD—melanoma	2.09e-06	9.71e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HRAS—melanoma	2.09e-06	9.69e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—melanoma	2.09e-06	9.68e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—melanoma	2.08e-06	9.67e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HRAS—melanoma	2.07e-06	9.59e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—melanoma	2.07e-06	9.59e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—melanoma	2.07e-06	9.59e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—melanoma	2.06e-06	9.58e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—melanoma	2.06e-06	9.56e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—melanoma	2.06e-06	9.55e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—melanoma	2.05e-06	9.53e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—melanoma	2.05e-06	9.52e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	2.04e-06	9.49e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK1—melanoma	2.04e-06	9.47e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—melanoma	2.04e-06	9.47e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—melanoma	2.04e-06	9.47e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—melanoma	2.04e-06	9.46e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—melanoma	2.03e-06	9.44e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NRAS—melanoma	2.03e-06	9.43e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—melanoma	2.03e-06	9.43e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NFKB1—melanoma	2.03e-06	9.42e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—melanoma	2.02e-06	9.4e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—melanoma	2.02e-06	9.38e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—melanoma	2.02e-06	9.38e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—melanoma	2.02e-06	9.37e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—melanoma	2.01e-06	9.35e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK1—melanoma	2.01e-06	9.32e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—melanoma	2.01e-06	9.32e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—melanoma	2.01e-06	9.32e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—melanoma	2e-06	9.31e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—melanoma	2e-06	9.31e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PRKCA—melanoma	2e-06	9.3e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—melanoma	2e-06	9.29e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NRAS—melanoma	2e-06	9.28e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CB—melanoma	2e-06	9.28e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—melanoma	2e-06	9.28e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NRAS—melanoma	2e-06	9.26e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—melanoma	1.99e-06	9.26e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—melanoma	1.99e-06	9.25e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—melanoma	1.99e-06	9.23e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NRAS—melanoma	1.99e-06	9.23e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—melanoma	1.99e-06	9.23e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—melanoma	1.99e-06	9.23e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ERCC2—melanoma	1.99e-06	9.22e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NRAS—melanoma	1.98e-06	9.2e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—melanoma	1.98e-06	9.2e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—melanoma	1.98e-06	9.2e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—melanoma	1.98e-06	9.2e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—melanoma	1.98e-06	9.18e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HRAS—melanoma	1.97e-06	9.14e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—melanoma	1.97e-06	9.14e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NRAS—melanoma	1.96e-06	9.11e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—melanoma	1.96e-06	9.11e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—melanoma	1.96e-06	9.11e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARG—melanoma	1.96e-06	9.11e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NRAS—melanoma	1.96e-06	9.09e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CB—melanoma	1.95e-06	9.06e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK3—melanoma	1.95e-06	9.04e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HRAS—melanoma	1.94e-06	9.02e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—melanoma	1.93e-06	8.98e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—melanoma	1.93e-06	8.97e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—melanoma	1.93e-06	8.95e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—melanoma	1.92e-06	8.93e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK3—melanoma	1.92e-06	8.89e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK3—melanoma	1.91e-06	8.87e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—melanoma	1.91e-06	8.85e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK3—melanoma	1.91e-06	8.84e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK3—melanoma	1.9e-06	8.81e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—melanoma	1.9e-06	8.81e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	1.9e-06	8.8e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—melanoma	1.89e-06	8.79e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—melanoma	1.89e-06	8.75e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK3—melanoma	1.88e-06	8.73e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK3—melanoma	1.88e-06	8.7e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—melanoma	1.88e-06	8.7e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—melanoma	1.86e-06	8.65e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—melanoma	1.86e-06	8.63e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—melanoma	1.86e-06	8.63e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—melanoma	1.85e-06	8.6e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK1—melanoma	1.85e-06	8.6e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—melanoma	1.85e-06	8.6e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—melanoma	1.85e-06	8.57e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—melanoma	1.84e-06	8.56e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—melanoma	1.84e-06	8.55e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CB—melanoma	1.84e-06	8.54e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—melanoma	1.83e-06	8.51e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—melanoma	1.83e-06	8.5e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—melanoma	1.83e-06	8.49e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—melanoma	1.82e-06	8.47e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—melanoma	1.82e-06	8.47e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—melanoma	1.82e-06	8.47e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CB—melanoma	1.82e-06	8.46e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK1—melanoma	1.82e-06	8.46e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—melanoma	1.82e-06	8.46e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—melanoma	1.82e-06	8.46e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—melanoma	1.82e-06	8.45e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NRAS—melanoma	1.82e-06	8.45e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK1—melanoma	1.82e-06	8.44e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—melanoma	1.82e-06	8.44e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK1—melanoma	1.81e-06	8.41e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—melanoma	1.81e-06	8.41e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK1—melanoma	1.81e-06	8.39e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—melanoma	1.81e-06	8.39e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—melanoma	1.81e-06	8.39e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK1—melanoma	1.79e-06	8.31e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—melanoma	1.79e-06	8.3e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CD—melanoma	1.79e-06	8.3e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK1—melanoma	1.78e-06	8.28e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—melanoma	1.78e-06	8.28e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	1.77e-06	8.22e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—melanoma	1.77e-06	8.22e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—melanoma	1.76e-06	8.19e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—melanoma	1.76e-06	8.18e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HRAS—melanoma	1.75e-06	8.14e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—melanoma	1.75e-06	8.12e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	1.74e-06	8.09e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK3—melanoma	1.74e-06	8.09e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—melanoma	1.74e-06	8.07e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—melanoma	1.73e-06	8.03e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—melanoma	1.73e-06	8.02e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—melanoma	1.72e-06	7.99e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—melanoma	1.72e-06	7.99e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—melanoma	1.72e-06	7.97e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—melanoma	1.72e-06	7.96e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—melanoma	1.71e-06	7.95e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—melanoma	1.71e-06	7.95e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—melanoma	1.71e-06	7.92e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—melanoma	1.69e-06	7.87e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HRAS—melanoma	1.69e-06	7.86e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—melanoma	1.69e-06	7.84e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—melanoma	1.69e-06	7.83e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—melanoma	1.69e-06	7.83e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—melanoma	1.69e-06	7.82e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HRAS—melanoma	1.68e-06	7.82e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—melanoma	1.68e-06	7.79e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK1—melanoma	1.66e-06	7.7e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—melanoma	1.66e-06	7.69e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HRAS—melanoma	1.64e-06	7.61e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—melanoma	1.62e-06	7.52e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HRAS—melanoma	1.61e-06	7.49e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—melanoma	1.61e-06	7.49e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—melanoma	1.61e-06	7.46e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—melanoma	1.59e-06	7.38e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—melanoma	1.58e-06	7.34e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—melanoma	1.58e-06	7.32e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—melanoma	1.58e-06	7.31e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—melanoma	1.57e-06	7.3e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—melanoma	1.57e-06	7.28e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—melanoma	1.57e-06	7.28e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—melanoma	1.57e-06	7.28e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—melanoma	1.57e-06	7.27e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CB—melanoma	1.56e-06	7.23e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—melanoma	1.55e-06	7.22e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—melanoma	1.55e-06	7.21e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—melanoma	1.55e-06	7.19e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	1.55e-06	7.19e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—melanoma	1.54e-06	7.17e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—melanoma	1.54e-06	7.17e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—melanoma	1.53e-06	7.11e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—melanoma	1.53e-06	7.1e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—melanoma	1.53e-06	7.09e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—melanoma	1.52e-06	7.06e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—melanoma	1.52e-06	7.04e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARG—melanoma	1.51e-06	7.03e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—melanoma	1.5e-06	6.97e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—melanoma	1.5e-06	6.95e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—melanoma	1.5e-06	6.94e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—melanoma	1.49e-06	6.91e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HRAS—melanoma	1.49e-06	6.9e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HRAS—melanoma	1.46e-06	6.79e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HRAS—melanoma	1.46e-06	6.78e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HRAS—melanoma	1.46e-06	6.75e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HRAS—melanoma	1.45e-06	6.73e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—melanoma	1.45e-06	6.72e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	1.44e-06	6.68e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HRAS—melanoma	1.44e-06	6.67e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HRAS—melanoma	1.43e-06	6.65e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—melanoma	1.42e-06	6.61e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—melanoma	1.42e-06	6.61e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—melanoma	1.41e-06	6.52e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—melanoma	1.4e-06	6.5e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—melanoma	1.4e-06	6.49e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—melanoma	1.39e-06	6.47e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—melanoma	1.39e-06	6.46e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—melanoma	1.39e-06	6.44e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CD—melanoma	1.38e-06	6.4e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—melanoma	1.37e-06	6.38e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—melanoma	1.37e-06	6.36e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—melanoma	1.36e-06	6.32e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—melanoma	1.36e-06	6.3e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—melanoma	1.35e-06	6.25e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HRAS—melanoma	1.33e-06	6.18e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—melanoma	1.31e-06	6.09e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—melanoma	1.29e-06	6e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—melanoma	1.29e-06	5.98e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—melanoma	1.28e-06	5.96e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—melanoma	1.28e-06	5.95e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—melanoma	1.27e-06	5.91e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—melanoma	1.27e-06	5.89e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—melanoma	1.26e-06	5.87e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—melanoma	1.22e-06	5.66e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CB—melanoma	1.2e-06	5.58e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—melanoma	1.19e-06	5.53e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—melanoma	1.19e-06	5.52e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—melanoma	1.18e-06	5.46e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—melanoma	1.12e-06	5.2e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—melanoma	1.11e-06	5.16e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—melanoma	1.11e-06	5.15e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—melanoma	1.04e-06	4.82e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—melanoma	9.96e-07	4.62e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—melanoma	9.72e-07	4.51e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—melanoma	9.5e-07	4.41e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—melanoma	9.16e-07	4.25e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—melanoma	9.08e-07	4.21e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—melanoma	7.76e-07	3.6e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—melanoma	7.33e-07	3.4e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—melanoma	5.99e-07	2.78e-06	CbGpPWpGaD
